HOSPITAL UNIVERSITARIO DE GETAFE
Saila
New York University Langone Medical Center
Nueva York, Estados UnidosNew York University Langone Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2013
-
Evidence available on the use of the selective β3-adrenoceptor agonist mirabegron for the treatment of overactive bladder
Actas Urologicas Espanolas
-
Mirabegron for the treatment of overactive bladder: A prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies
International Journal of Clinical Practice, Vol. 67, Núm. 7, pp. 619-632